Le Lézard
Classified in: Health
Subjects: CCA, FVT

Petros Pharmaceuticals to Participate at Upcoming Benzinga Conference and Interview Show

NEW YORK, Oct. 21, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, announces today that President and Chief Commercial Officer Fady Boctor will participate in the following Benzinga events:

Benzinga All Access Show

Mr. Boctor will participate in Benzinga's All Access Show for a 20-minute interview on Friday, October 22, 2021 at 1:05 PM ET.

During the interview, Mr. Boctor will discuss the latest corporate developments and future growth plans for the company.

Click here to watch:   https://www.youtube.com/watch?v=zTUbSg_HVrQ

Benzinga Global Small Cap Conference

Mr. Boctor will present a corporate overview at the Benzinga Global Small Cap Conference, which is being held virtually on October 27 ? 28, 2021.

Mr. Boctor will deliver his corporate presentation on Wednesday, October 27 at 2:40 PM ET.

Mr. Boctor will be available for one-on-one meetings throughout the conference.

Register for the conference HERE

About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.

SOURCE Petros Pharmaceuticals, Inc.

These press releases may also interest you

at 21:30
The "Genome Engineering Market by Technology and Geography - Forecast and Analysis 2021-2025" report has been added to Technavio's offering. With ISO 9001:2015 certification, Technavio is proudly partnering with more than 100 Fortune 500 companies...

at 21:00
The "In-vitro Diagnostics Market - Competitive Analysis, Drivers, Challenges, and  Five Force Analysis" report has been added to Technavio's offering. The In-vitro diagnostics market is set to grow by USD 35.77 billion, progressing at a CAGR of 7.95%...

at 20:11
China-Africa friendship is expected to continue to flourish as cooperation is further deepened in various areas after the ongoing 8th Ministerial Conference of the Forum on China-Africa Cooperation (FOCAC) held in Dakar, Senegal....

at 20:00
Shanghai Junshi Biosciences Co., Ltd. ("Junshi Biosciences", HKEX: 1877; SSE: 688180) announced today that the National Medical Products Administration (NMPA) of China has approved its supplemental New Drug Application (sNDA) for toripalimab in...

at 19:32
Jelly Jim, a leader in the nutraceutical space, is prepared to welcome a new Q4 full of increased sales due to seasonal buyers. Over the past couple of years, the nutraceutical space has seen more season purchasers year over year and this year is no...

at 19:14
Expanded clinical infrastructure to support a growing portfolio of clinical trials of novel interventions and for drug discovery; 14 registered clinical trials in depression, led by Company CEO and Chief Medical and Scientific Officer, completed or...

News published on 21 october 2021 at 09:25 and distributed by: